Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

8
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
Mar 25, 2022
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
Sep 21, 2022
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research report
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research
If the objective of biomedical research is to spur innovation to create healthier communities, exte
nd life, and more effectively treat or cure disease, then persistent inequities run counter to that goal and create unnecessary barriers to health and wel
Apr 6, 2023
Toward a National Action Plan for Achieving Diversity in Clinical Trials report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
May 6, 2024
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
Jul 1, 2024
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561 article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth Associate Commissioner for Policy Food and Drug Administration 5630 Fishers Lane, Rm.
1061 Rockville, MD 20852 Dear Ms. Roth,
Apr 29, 2024
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package article
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package
The Milken Institute applauds Congress on the passage of the FY2023 Omnibus Appropriations bill.
Dec 23, 2022
Building and Sustaining Diversity & Equity in Digital Health Workshop video
Building and Sustaining Diversity & Equity in Digital Health Workshop
Digital health innovations have the ability to improve overall health and provide patients with ma
ny benefits. But is digital health representative and accessible to everyone?
Feb 28, 2023